As a synthetic compound, Sculptra is injected into the body where it progressively thickens the skin. The fat is replaced by volume so that the loss of fat is no longer noticeable. Since Sculptra is composed entirely of poly-L-lactic acid which is a synthetic material no skin test is required for use in patients. The elimination of the testing process ensures Sculptra as a more efficient form of treatment. Used internationally since 1999, Sculptra has helped an estimated 150,000 patients in over 30 countries. The treatment became widespread due to its consistent and lasting results. In May 2002 Dermik Laboratories, a United States company, acquired Sculptra and since then it has become a popular method for treating Lipoatrophy in this country. The FDA approved Sculptra in the United States on August 3, 2004.Request a Consultation
Dr. Adrienne Stewart has been in private practice since 1990 and has given various lectures on aging skin, skin cancer, and hyperpigmentation.
Education & Professional Experience BA, Tulane University (French), Phi Beta Kappa, Magna Cum Laude, 1981 Tulane University School of Medicine, 1982-1986 Flexible Internship, Tulane Charity Hospital, 1986-1987 Dermatology Residency - Tulane, 1987-1990 Chief Resident of Dermatology, 1990 Board Certified in Dermatology, 1990 Professional Certifications & Affiliations Fellow, American Academy of Dermatology Member, American Society of Dermatologic Surgery Member, Colorado Dermatology Society Member, Denver Medical Society President, Colorado Dermatologic Society (2005) Speaker for GlaxoSmith Kline, Skin Medica, ICN, Allergan and Collagenix. Studies performed for Differin, Tazorac, Retin-A, Tri Luma and Meto Lotion. National Education Faculty Member for Allergan - Botox training center